Syngene International

BSE : 539268 | NSE : SYNGENE
Industry : Pharmaceuticals | ISIN : INE398R01022 | FreeFloat : 34.18% | FnO : Yes | LotSize : 1000
Intellectual Capital (IC)1,475.29
Net Worth (NW)3,375.90
Intrinsic Worth (IW)4,851.19
Market Cap (MC)23,506.00
Economic Value Added-17.33
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)30.41%
IC Gross Margin (EBITDA/IC)69.58%
IC Net Margin (NPT/IC)24.28%
Knowledge Turnover (Sales/IC)2.10
Market to Intrinsic Value (MC/IW)4.85
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 120.85Rs. 585.55
27 Mar 2023 ---- Rs. 577.35
2.15     0.37%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 578.58AccumulateSell on Rallies
KB > 50% : No50 DMA : Rs. 577.83
0 < M2IV < 1 : NoVol-Price trend : Rising
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
607.30
627.80
86.90
24.60
15.30
12.02
-1.38
Jun-20
C
421.60
436.90
139.80
73.70
66.30
58.00
85.30
Sep-20
C
519.60
533.40
169.50
100.80
94.20
84.10
93.35
Dec-20
C
584.50
601.60
193.30
123.60
116.50
102.20
141.80
Mar-21
C
658.60
677.00
268.80
198.80
192.20
160.60
194.80
Jun-21
C
594.50
606.80
177.30
102.60
94.70
77.30
62.20
Sep-21
C
610.20
623.10
159.60
83.40
82.20
66.70
98.60
Dec-21
C
641.40
654.30
216.30
137.80
128.40
104.00
122.50
Mar-22
C
758.10
772.80
265.00
184.70
179.10
147.80
148.00
Jun-22
C
644.50
660.00
188.30
102.20
92.80
73.90
-23.00
Sep-22
C
768.10
783.50
231.90
141.70
130.00
102.00
61.30
Dec-22
C
785.90
803.10
248.20
153.60
139.90
109.70
102.00
* C - Consolidated, S - Standalone